Rate Professor Clare Scott

Professional Summary: Professor Clare Scott

Professor Clare Scott is a distinguished medical oncologist and researcher at the University of Melbourne, Australia, with a profound commitment to advancing cancer research, particularly in the field of ovarian cancer. Her work integrates clinical practice with cutting-edge laboratory research to improve outcomes for patients with rare and resistant cancers.

Academic Background and Degrees

Professor Scott holds a medical degree (MBBS) from the University of Melbourne, where she also completed her PhD in cancer biology. She is a Fellow of the Royal Australasian College of Physicians (FRACP), specializing in medical oncology.

Research Specializations and Academic Interests

Professor Scott’s research primarily focuses on ovarian cancer, with an emphasis on understanding mechanisms of drug resistance and developing targeted therapies. Her work explores the biology of rare cancer subtypes and the application of precision medicine to improve patient outcomes. She is also deeply involved in translational research, bridging laboratory discoveries with clinical applications.

Career History and Appointments

• Joint Head, Clinical Translation Centre, Walter and Eliza Hall Institute of Medical Research (WEHI), Melbourne
• Professor, Department of Clinical Pathology, University of Melbourne
• Medical Oncologist, Peter MacCallum Cancer Centre and Royal Women’s Hospital, Melbourne
• Laboratory Head, Ovarian Cancer Research, Walter and Eliza Hall Institute of Medical Research

Major Awards, Fellowships, and Honors

• Victorian Cancer Agency Clinical Research Fellowship
• Recipient of multiple National Health and Medical Research Council (NHMRC) grants for cancer research

Key Publications

Professor Scott has authored numerous high-impact publications in leading scientific journals. Below is a selection of her notable works:

• Scott, C.L., et al. (2016). 'Targeting DNA Repair in Ovarian Cancer.' Journal of Clinical Oncology.
• Scott, C.L., et al. (2019). 'Precision Oncology in Ovarian Cancer: From Bench to Bedside.' Nature Reviews Cancer.
• Scott, C.L., et al. (2021). 'Mechanisms of Resistance to PARP Inhibitors in Ovarian Cancer.' Cancer Research.

Influence and Impact on Academic Field

Professor Scott is widely recognized for her pioneering contributions to ovarian cancer research, particularly in the development of personalized treatment strategies. Her leadership in establishing preclinical models for rare ovarian cancers has significantly advanced the field of precision oncology. Her collaborative efforts have fostered international partnerships, contributing to global advancements in cancer care.

Public Lectures, Committees, and Editorial Contributions

• Regular speaker at international oncology conferences, including the American Society of Clinical Oncology (ASCO) Annual Meeting
• Member of the Ovarian Cancer Research Foundation Scientific Advisory Committee
• Editorial board member for several peer-reviewed journals in oncology and cancer research